Strides Arcolab Limited has sold 94 per cent shareholding in Ascent Pharmahealth Limited, its subsidiary with operations in Australia and Southeast Asia, to Watson Pharmaceuticals, Inc.  As part of the transaction, Watson also acquired the remaining 6 per cent shareholding associated with Dennis Bastas, CEO of Ascent.  The transaction was signed and closed simultaneously.  The … Continue reading Strides sells generics business in Australia & Southeast Asia to Watson Pharma for Rs. 1970-cr